Additionally, the increases in IL-4 and IL-10 levels point to a shift towards an anti-inflammatory state, promoting a favourable immunological environment that could benefit diabetes management by mitigating chronic inflammation. This evidence concerns the gene IL10 and diabetes mellitus.